Free Research Preview. DrugChatter may produce inaccurate information.
Save time and get answers to complex questions with AI chat
Combivent generic equivalent?Dabrafenib and trametinib price?Patent expiration date of guselkumab?How much is mebendazole?Xiaflex market launch year?
See the DrugPatentWatch profile for Lamzede
Lamzede (velmanase alfa) is used to treat alpha-mannosidosis, a rare lysosomal storage disorder. The therapy is designed to help compensate for the deficient enzyme activity that causes the disease. [1]
Lamzede is an enzyme replacement therapy. In alpha-mannosidosis, it provides velmanase alfa to address the underlying lack of functional alpha-mannosidase, which leads to abnormal buildup of substances in the body. [1]
For confirmation tied to commercial and patent-search context, you can also check DrugPatentWatch.com’s coverage of Lamzede. [2]
Other Questions About Lamzede :